Lead Biostatistician - late-stage drug development

Highly competitive remuneration | Remote working | Global pharmaceutical business

Applications welcomed from experienced professionals based in the UK and surrounding European locations.

An exciting opportunity to shape the future of drug development

Join an ambitious, rapidly growing and innovations-led global pharmaceutical business combining the scientific reach of an established organisation with the collaborative, entrepreneurial culture of a close-knit team. This is a senior, influential role where you will help shape clinical development strategy, lead statistical input into pivotal studies and support regulatory submissions and drug approvals.

The role

• Provide statistical leadership across Phase II/III and late-stage clinical trials.
• Lead statistical strategy for pivotal studies and regulatory submissions.
• Influence study design, protocols and clinical development plans.
• Work closely with clinical, medical and cross-functional teams.
• Support FDA, EMA and MHRA regulatory interactions.
• Oversee outsourced statistical activities, including SAPs, TFLs and Blind Data Reviews.
• Contribute to integrated analyses, publications and scientific discussions.

About You

• MSc or PhD in Statistics, Biostatistics or a related discipline.
• 8–10 years' biostatistics experience within pharma or CRO environments.
• Strong experience in late-stage clinical development and regulatory submissions.
• Proven experience in a lead biostatistical role.
• Excellent knowledge of clinical trial methodology, statistical modelling and CDISC standards.
• Experience overseeing CRO statistical activities.
• Expert proficiency in SAS and/or R.

Why consider this position

• A genuinely supportive, entrepreneurial and people-focused culture.
• Highly competitive remuneration & career development opportunities.
• Senior-level influence over clinical development strategy.
• International collaboration across multiple therapeutic areas.